Critical von Willebrand factor A1 domain residues influence type VI collagen binding
- 16 April 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 10 (7), 1417-1424
- https://doi.org/10.1111/j.1538-7836.2012.04746.x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactorBlood, 2010
- Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWDJournal of Thrombosis and Haemostasis, 2010
- Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factorBlood, 2009
- An Update on the von Willebrand Factor Collagen Binding Assay: 21 Years of Age and Beyond Adolescence but Not Yet a Mature AdultSeminars in Thrombosis and Hemostasis, 2007
- The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort studyBlood, 2007
- Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survivalBlood, 2006
- The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort studyBlood, 2006
- A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)Journal of Thrombosis and Haemostasis, 2006
- 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.JCI Insight, 1991
- The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.JCI Insight, 1991